Abdelli Nedra, Francisco Pérez José, Vilarrasa Ester, Melo-Duran Diego, Cabeza Luna Irene, Karimirad Razzagh, Solà-Oriol David
Animal Nutrition and Welfare Service (SNIBA), Department of Animal and Science, Facultat de Veterinària, Universitat Autònoma de Barcelona, Barcelona, Spain.
FARMFAES-TECNOVIT, Alforja, Spain.
Front Vet Sci. 2021 Oct 15;8:686143. doi: 10.3389/fvets.2021.686143. eCollection 2021.
The first objective of this study was to demonstrate the usefulness of the microencapsulation technique to protect fumaric acid and thymol, avoiding their early absorption and ensuring their slow release throughout the gastrointestinal tract (GIT). For this purpose, the release of a lipid matrix microencapsulated brilliant blue (BB) was assessed , using a simulated broiler intestinal fluid, and . results showed that more than 60% of BB color reached the lower intestine, including 26.6 and 29.7% in the jejunum and ileum, respectively. The second objective was to determine the effects of microencapsulated fumaric acid, thymol, and their mixture on the performance and gut health of broilers challenged with a short-term fasting period (FP). One-day-old male ROSS 308 chickens ( = 280) were randomly distributed into seven treatments, with 10 replicates of four birds each. Dietary treatments consisted of a basal diet as negative control (NC), which was then supplemented by either non-microencapsulated fumaric acid (0.9 g/kg), thymol (0.6 g/kg), or a mixture of them. The same additive doses were also administered in a microencapsulated form (1.5 and 3 g/kg for the fumaric acid and thymol, respectively). At day 21, chickens were subjected to a 16.5-h short-term FP to induce an increase in intestinal permeability. Growth performance was assessed weekly. At day 35, ileal tissue and cecal content were collected from one bird per replicate to analyze intestinal histomorphology and microbiota, respectively. No treatment effect was observed on growth performance from day 1 to 21 ( > 0.05). Microencapsulated fumaric acid, thymol, or their mixture improved the overall FCR (feed conversion ratio) and increased ileal villi height-to-crypt depth ratio (VH:CD) ( < 0.001) on day 35 of the experiment. The microencapsulated mixture of fumaric acid and thymol increased cecal abundance of Bacteroidetes, Bacillaceae, and Rikenellaceae, while decreasing that of Pseudomonadaceae. These results indicate that the microencapsulation technique used in the current study can be useful to protect fumaric acid and thymol, avoiding early absorption, ensure their slow release throughout the GIT, and improve their effects on fasted broiler chickens.
本研究的首要目标是证明微囊化技术在保护富马酸和百里香酚方面的有效性,避免它们过早吸收,并确保它们在整个胃肠道(GIT)中缓慢释放。为此,使用模拟的肉鸡肠液评估了脂质基质微囊化亮蓝(BB)的释放情况。结果表明,超过60%的BB颜色到达了下肠道,其中在空肠和回肠中的比例分别为26.6%和29.7%。第二个目标是确定微囊化富马酸、百里香酚及其混合物对短期禁食期(FP)挑战的肉鸡生产性能和肠道健康的影响。1日龄雄性ROSS 308鸡(n = 280)被随机分为七个处理组,每组四个重复,每个重复四只鸡。日粮处理包括基础日粮作为阴性对照(NC),然后分别添加未微囊化的富马酸(0.9 g/kg)、百里香酚(0.6 g/kg)或它们的混合物。相同的添加剂量也以微囊化形式施用(富马酸和百里香酚分别为1.5和3 g/kg)。在第21天,对鸡进行16.5小时的短期禁食,以诱导肠道通透性增加。每周评估生长性能。在第35天,从每个重复中选取一只鸡收集回肠组织和盲肠内容物,分别分析肠道组织形态学和微生物群。在第1天至第21天未观察到处理对生长性能的影响(P>0.05)。在实验的第35天,微囊化富马酸、百里香酚或它们的混合物改善了总体饲料转化率(FCR),并增加了回肠绒毛高度与隐窝深度比(VH:CD)(P<0.001)。微囊化富马酸和百里香酚的混合物增加了盲肠中拟杆菌、芽孢杆菌科和理研菌科的丰度,同时降低了假单胞菌科的丰度。这些结果表明,本研究中使用的微囊化技术可有效保护富马酸和百里香酚,避免早期吸收,确保它们在整个胃肠道中缓慢释放,并改善它们对禁食肉鸡的影响。